Abstract
OBJECTIVE: To examine utilization of health-care resources among mothers and infants following cocaine use during pregnancy.
DESIGN:Prospective observational study.
SETTING:Four clinical sites.
PATIENTS/METHODS: Medical and social services resource use was examined among 8514 mother–infant dyads, 1072 of whom used cocaine and 7442 who did not. Use was stratified by <1500 g and >1500 g birth-weight strata to differentiate the low birth weight from the larger weight group adjusting for site, infant gender, and maternal race and education.
OUTCOME MEASURES:Resource use evaluated among mothers included prenatal care, hospitalizations, medications and mode of delivery. Resource use for infants included therapies, procedures and length of stay.
RESULTS: Fewer cocaine-exposed women, compared to those in the nonexposed group, had prenatal care or used medications during pregnancy in both <1500 g category 0.10 (0.04 to 0.22) (OR (99% CI) and 0.26 (0.10 to 0.65), respectively, and in the >1500 g category 0.14 (0.11 to 0.19) and 0.61 (0.49 to 0.74), respectively. Length of hospital stay for social reasons and referrals to child protective services were increased in cocaine-exposed infants in both <1500 g category 66.8 (4.38 to 999.9) and 77.4 (17.64 to 289.13), respectively and in the >1500 g category 70.74 (41.73 to 119.94) and 125.88 (81.78 to 193.77), respectively. In addition, among >1500 g cocaine-exposed infants, length of stay in neonatal intensive care unit was increased 1.53 (1.16 to 2.02) as was therapies 1.76 (1.45 to 2.13), procedures 1.50 (1.23 to 1.83), need for formula feeds 5.45 (2.28 to 13.02) and intravenous fluids 1.50 (1.19 to 1.87),
CONCLUSION: Cocaine exposure has no deleterious or protective effects on medical resource needs of <1500 g infants or their mothers. Resource needs reflect those of morbidity of being born premature. The increase in health-care resources for >1500 g cocaine-exposed infants for surveillance and monitoring in the absence of an increase in congenital anomalies should be discouraged.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Behnke M, Eyler FD, Garvan CW, Wobie K . The search for congenital malformations in newborns with fetal cocaine exposure. Pediatrics 2001;107:e74.
Forsyth BWC, Leventhal JM, Qi K, Johnson L, Schroeder D, Votto N . Health care and hospitalizations of young children born to cocaine-using women. Arch Pediatr Adolesc Med 1998;152:177–184.
Stichler JF, Weiss M, Wight NE . Examining the “cost” of substance abuse in pregnancy: patient outcomes and resource utilization. J Perinatol 1998;18:384–388.
Kliegman RM, Madura D, Kiwi R, Eisenberg I, Yamashita T . Relation of maternal cocaine use to the risks of prematurity and low birth weight. J Pediatr 1994;124:751–756.
Behnke M, Eyler FD, Conlon M, Casanova OQ, Woods NS . How fetal cocaine exposure increases neonatal hospital costs. Pediatrics 1997;99:204–208.
Phibbs CS, Bateman DA, Schwartz RM . The neonatal costs of maternal cocaine use. JAMA 1991;266:1521–1526.
U.S. Department of Health and Human Services Administration on Children, Youth and Families Children's Bureau. Report to the Congress. National Estimates on the Number of Boarder Babies, the Cost of their Care and Number of Abandoned Infants. U.S. Government Printing Office, 1994;1–42.
Joyce T, Racine AD, McCalla S, Wehbeh H . The impact of prenatal exposure to cocaine on newborn costs and length of stay. Health Serv Res 1995;30:341–358.
Bauer CR, Shankaran S, Bada HS, et al. Maternal lifestyle study (MLS): effects of substance exposure during pregnancy on acute infant outcomes. Pediatr Res 1996;39:257 (Abstract).
Ostrea EM, Brady M, Gause S, Raymundo AL, Stevens M . Drug screening of newborns by meconium analysis: a large-scale, prospective, epidemiologic study. Pediatrics 1992;89:107–113.
Bauer CR, Shankaran S, Bada HS, et al. The Maternal Lifestyle Study (MLS): drug exposure during pregnancy and acute maternal outcomes. Am J Obstet Gynecol 2002;186:487–495.
Lester BM, ElSohly M, Wright LL, et al. The Maternal lifestyle study (MLS): drug use by meconium toxicology and maternal self report. Pediatrics 2001;107:309–317.
U.S. General Accounting Office (GAO). Report to the Chairman, Committee on Finance, U.S. Senate. Drug Exposed Infants. A Generation at Risk. Washington, DC: U.S. GAO; 1990.
U.S. Department of Health and Human Services. Drug Use among Racial/Ethnic Minorities. National Institute on Drug Abuse. Public Health Service. NIH Publication No. 95-3888. Washington, DC: U.S. Government Printing Office, 1995.
SAS Institute Inc. SAS language: Reference, Version 6. 1st ed. Cary, NC: SAS Institute Inc; 1990.
Racine A, Joyce T, Anderson R . The association between prenatal care and birth weight among women exposed to cocaine in New York City. JAMA 1993;270:1581–1586.
Calhoun BC, Watson PT . The cost of maternal cocaine abuse: I. Perinatal cost. Obstet Gynecol 1991;78:731–734.
Chiu TTW, Vaughn AJ, Carzoli RP . Hospital costs for cocaine-exposed infants. J. FL Med Assoc 1990;77:897–900.
Eyler FD, Behnke M, Conlon M, Woods NS, Frentzen B . Prenatal cocaine use: A comparison of neonates matched on maternal risk factors. Neurotoxi Teratol 1994;16:81–87.
Frank DA, McCarten KM, Robson CD, et al. Level of in utero cocaine exposure and neonatal ultrasound findings. Pediatrics 1999;104:1101–1105.
Shankaran S . Hemorrhagic lesions of the central nervous system. In: Stevenson D, Sunshine P, editors. Fetal and Neonatal Brain Injury: Mechanisms, Management, and Risks of Practice. 2nd editors., Oxford: Oxford University Press, 1997, p. 151–164.
Takayama JI, Bergman AB, Connell FA . Children in foster care in the state of Washington. JAMA 1994;271:1850–1855.
Fox K, Merrill JC, Chang H, Califano JA . Estimating the costs of substance abuse to the Medicaid hospital care program. Am J Public Health 1995;85:48–54.
Author information
Authors and Affiliations
Additional information
This study was supported by the National Institute of Child Health and Human Development through cooperative agreements (U10 HD 21385) (S.S.), (U10 HD 21397)(C.R.B.), (U10 HD 27856) (H.S.B.), (U10 HD 27904) (B.L.), (U01 HD 36790) (A.D.).
Rights and permissions
About this article
Cite this article
Shankaran, S., Bauer, C., Bada, H. et al. Health-care Utilization among Mothers and Infants Following Cocaine Exposure. J Perinatol 23, 361–367 (2003). https://doi.org/10.1038/sj.jp.7210946
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jp.7210946
This article is cited by
-
Predictors of Inadequate Prenatal Care in Methamphetamine-Using Mothers in New Zealand and the United States
Maternal and Child Health Journal (2013)
-
High Lifetime Pregnancy and Low Contraceptive Usage Among Sex Workers Who Use Drugs- An Unmet Reproductive Health Need
BMC Pregnancy and Childbirth (2011)
-
Mortality Risk Associated with Perinatal Drug and Alcohol Use in California
Journal of Perinatology (2005)